Earlier this year, panelists at an FDA workshop on next-generation sequencing standards advised the FDA that it should involve multiple stakeholders in crafting any standards and pressed for flexibility in the standards to accommodate the rapidly developing nature of the technology. (See NIR, Mar. 9, 2015, p. 1) Building on the discussions started at that…
Two FDA Workshops Focus on Precision Medicine Issues
by Glenn S. Demby | Sep 24, 2015 | FDA-nir, Focus On-nir, National Lab Reporter